Jan 29, 2026
What are the clinical effects and side‑effects of Bydureon compared with other Type 2 diabetes treatments?
( extended‑release) is a once‑weekly GLP‑1 receptor agonist that reduces HbA1c and improves versus placebo and many oral agents, but its efficacy for weight loss and magnitude of glycemic lowering app...